Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access in Pediatric Patients

19. december 2014 opdateret af: Vidacare Corporation

A Pilot Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation Using Rocuronium as the Paralytic Agent

This study will evaluate using intraosseous vascular access and intravenous vascular access to give pediatric patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties.

Studieoversigt

Status

Trukket tilbage

Betingelser

Undersøgelsestype

Observationel

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Nebraska
      • Omaha, Nebraska, Forenede Stater, 68198
        • Omaha Children's Hospital and Medical Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

patients in the emergency department with airway difficulties requiring rapid sequence intubation.

Beskrivelse

Inclusion Criteria:

  • subjects requiring rapid sequence intubation for whom rocuronium is chosen as the paralytic agent.
  • the operator chooses to place a peripheral intravenous or powered intraosseous catheter to permit rapid sequence intubation.

Exclusion Criteria:

  • subjects in whom vascular access for rapid sequence intubation drug administration was established prior to arrival to the emergency department.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intraosseous (IO) drug delivery
patients in whom intraosseous (IO) vascular access has been established for rapid sequence intubation drug delivery.
Peripheral intravenous (IV) drug delivery
patients in whom peripheral intravenous (IV) vascular access has been established for rapid sequence intubation drug delivery.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Time from determination of need for vascular access for rapid sequence intubation to administration of first does of paralytic agent.
Tidsramme: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes
Time from vascular access to intubation first attempt, as indicated by the first attempt to visualize the larynx with the laryngoscope.
Tidsramme: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes
time from vascular access to successful intubation
Tidsramme: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes
number of attempts necessary for successful intubation
Tidsramme: during rapid sequence intubation procedure, average expected time frame 30 minutes
during rapid sequence intubation procedure, average expected time frame 30 minutes

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Intubation difficulty
Tidsramme: during rapid sequence intubation procedure, average time frame 30 minutes
The Intubation Difficulty Scale is a validated tool used to grade the difficulty with which a patient was intubated for airway managment during rapid sequence intubation.
during rapid sequence intubation procedure, average time frame 30 minutes
operator satisfaction with intubating conditions
Tidsramme: during rapid sequence intubation procedure, average time frame 30 minutes
during rapid sequence intubation procedure, average time frame 30 minutes
failure rate of endotracheal intubation
Tidsramme: during rapid sequence intubation procedure, average time frame 30 minutes
failure rate of endotracheal intubation and requirement for alternative airway management.
during rapid sequence intubation procedure, average time frame 30 minutes
Time from presentation of patient to vascular access established
Tidsramme: during rapid sequence intubation procedure, average time frame 30 minutes
during rapid sequence intubation procedure, average time frame 30 minutes
Determine the incidence of short term catheter related complications for each technique
Tidsramme: during emergency department stay, average time frame 24 hours
during emergency department stay, average time frame 24 hours

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Edward Truemper, MD, University of Nebraska

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2012

Primær færdiggørelse (Faktiske)

1. august 2014

Studieafslutning (Faktiske)

1. august 2014

Datoer for studieregistrering

Først indsendt

2. juli 2012

Først indsendt, der opfyldte QC-kriterier

5. juli 2012

Først opslået (Skøn)

6. juli 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

23. december 2014

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

19. december 2014

Sidst verificeret

1. december 2014

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2012-03

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Luftvejskontrol

3
Abonner